Low Dose Metronomic Gemcitabine has High Antimetastatic Efficacy in an Orthotopic Mouse Model of Pancreatic Cancer

被引：0
|
作者：
Cao, H. S. Tran [1 ]
Bouvet, M. [1 ]
Romney, E. [2 ]
Kaushal, S. [1 ]
Keleman, A. [2 ]
Kim, G. [2 ]
Fruehauf, J. [2 ]
Imagawa, D. K. [2 ]
Hoffman, R. M. [3 ]
Katz, M. H. [2 ]
机构：
[1] UC San Diego, San Diego, CA USA
[2] UC Irvine, Orange, CA USA
[3] Anticancer Inc, San Diego, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [41] Effect of Endostar Combined with Gemcitabine on the Mouse Model of Human Pancreatic Cancer
    林青凤
    实用临床医药杂志, 2007, (03) : 19 - 23
  • [42] Anti-tumor efficacy of a mesothelin-based nanovaccine in a KPC orthotopic mouse model of pancreatic cancer
    Ferrari, Daniele
    Markus, Andrea
    Cobanoglu, Ozmen
    Sayedipour, Sana
    Luna, Omar
    Ferkel, Sonia
    Agorku, David
    Cruz, Luis
    Albericio, Fernando
    Trottein, Francois
    Alves, Frauke
    Ramos-Gomes, Fernanda
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 799 - 799
  • [43] Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer
    Ferrari, Daniele P.
    Cobanoglu, Ozmen
    Sayedipour, Sana
    Luna, Omar
    Ferkel, Sonia A. M.
    Agorku, David
    Perez, Yomkippur
    Cruz, Luis J.
    Albericio, Fernando
    Trottein, Francois
    Alves, Frauke
    Markus, Marietta Andrea
    Ramos-Gomes, Fernanda
    VACCINES, 2025, 13 (03)
  • [44] Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer
    Hahn, Ho-Suap
    Lee, Ki-Heon
    Lee, In-Ho
    Lee, Jae-Ho
    Whang, Chang-Sung
    Jo, Yeong-Woo
    Kim, Tae-Jin
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2014, 25 (02) : 130 - 135
  • [45] Effect of Low-Dose Gemcitabine on Unresectable Pancreatic Cancer in Elderly Patients
    Matsumoto, Kazuyuki
    Miyake, Yasuhiro
    Kato, Hironari
    Kawamoto, Hirofumi
    Imagawa, Atsushi
    Toyokawa, Tatsuya
    Nakatsu, Morihito
    Ando, Masaharu
    Hirohata, Mamoru
    Yamamoto, Kazuhide
    DIGESTION, 2011, 84 (03) : 230 - 235
  • [46] RADIOTHERAPY WITH CONCOMITANT WEEKLY LOW DOSE GEMCITABINE FOR LOCALLY ADVANCED PANCREATIC CANCER
    Kawaguchi, A.
    Yokokawa, M.
    Ikeda, S.
    Masahiro, M.
    Kawabata, Y.
    Yano, S.
    Tanaka, T.
    Uchida, N.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S368 - S369
  • [47] EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model
    Singh, Amit
    Xu, Jing
    Mattheolabakis, George
    Amiji, Mansoor
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (03) : 589 - 600
  • [48] MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model
    Kawaguchi, Kei
    Igarashi, Kentaro
    Miyake, Kentaro
    Lwin, Thinzar M.
    Miyake, Masuyo
    Kiyuna, Tasuku
    Hwang, Ho Kyoung
    Murakami, Takashi
    Delong, Jonathan C.
    Singh, Shree Ram
    Clary, Bryan
    Bouvet, Michael
    Unno, Michiaki
    Hoffman, Robert M.
    TISSUE & CELL, 2018, 52 : 124 - 128
  • [49] Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts
    Pratt, Susan E.
    Durland-Busbice, Sara
    Shepard, Robert L.
    Donoho, Gregory P.
    Starling, James J.
    Wickremsinhe, Enaksha R.
    Perkins, Everett J.
    Dantzig, Anne H.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (04) : 481 - 490
  • [50] Optimization of an Orthotopic Mouse Model of Pancreatic Cancer to Simulate Liver Metastasis and Cancer Cachexia
    Wang, David J.
    Spadafora, Victoria
    Pryce, Benjamin R.
    Oles, Alexander
    Talbert, Erin E.
    Ostrowski, Micheal C.
    Guttridge, Denis C.
    CANCER RESEARCH, 2024, 84 (17)
12345